Results 271 to 280 of about 2,656,785 (305)
Some of the next articles are maybe not open access.

Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling

Journal of Drug Targeting, 2012
Hedgehog (Hh) signaling is involved in the pathogenesis of liver fibrosis. It has been previously shown that Hh-inhibitor cyclopamine (CYA) can reduce liver fibrosis in rats. However, CYA is not stable in vivo, which limits its clinical application.
Akshay Pratap   +6 more
semanticscholar   +3 more sources

Myocardial Preconditioning Potential of Hedgehog Activator Purmorphamine (Smoothened Receptor Agonist) against Ischemia-Reperfusion in Deoxycortisone Acetate Salt-Induced Hypertensive Rat Hearts

Journal of Pharmacology and Pharmacotherapeutics, 2019
Aim: To investigate the myocardial preconditioning potential of hedgehog activator smoothened (SMO) receptor agonist purmorphamine (PUR) against ischemia-reperfusion (I/R) injury in deoxycortisone acetate (DOCA) salt-induced hypertensive rat heart ...
Himanshi Khera, Anupam Awasthi, S. Mehan
semanticscholar   +1 more source

Neuroprotective effects of a Smoothened receptor agonist against postoperative cognitive dysfunction by promoting autophagy in the dentate gyrus of aged rats

Neurological Research, 2019
Objectives: To investigate the effect of purmorphamine (PUR), a Shh co-receptor Smoothened (Smo) agonist, on postoperative cognitive dysfunction (POCD) rat models.
Pei Li   +6 more
semanticscholar   +1 more source

Three-Dimensional Structure of the Smoothened Receptor: Implications for Drug Discovery

, 2014
The recently described high resolution three-dimensional structures of the transmembrane and the extracellular domains of the human Smoothened (Smo) receptor higlight both conserved and unique structural features of this G protein-coupled receptor.
D. Rognan, I. Mus-Veteau
semanticscholar   +2 more sources

Smoothened receptor as a novel target for remyelination therapies

2021
Multiple Sclerosis (MS) is an autoimmune demyelinating disease of unknown aetiology, causing neurodegeneration in the Central Nervous System (CNS). Although the spontaneous capacity of myelin to regenerate can restore neuronal function, during MS progression, the instauration of an inflammatory microenvironment limits oligodendrocyte precursor cells ...
openaire   +2 more sources

[Structure of the Smoothened receptor].

Medecine sciences : M/S, 2014
The Smoothened (Smo) receptor is a major component involved in signal transduction of the Hedgehog (Hh) morphogens both during embryogenesis and in the adult. Smo antagonists represent a promi-sing alternative for the treatment of cancers linked to abnormal Hh signalling.
Martial, Ruat   +3 more
openaire   +1 more source

The seven-transmembrane receptor Smoothened cell-autonomously induces multiple ventral cell types

Nature Neuroscience, 2000
Sonic Hedgehog (Shh) is a secreted protein that controls cell fate and mitogenesis in the developing nervous system. Here we show that a constitutively active form of Smoothened (Smo-M2) mimics concentration-dependent actions of Shh in the developing neural tube, including activation of ventral marker genes (HNF3beta, patched, Nkx2.2, netrin-1 ...
M, Hynes   +6 more
openaire   +2 more sources

Pharmacological and structural studies on the hedgehog pathway receptor smoothened

2023
The Frizzled-class G protein-coupled receptor Smoothened (SMO) is an essential component of the Hedgehog (HH) signalling pathway, which is of paramount importance to developmental processes of bilaterians. Dysregulation of HH signalling has been implicated in multiple pathophysiological processes in adult organisms, such as cancer development.
openaire   +1 more source

Sonidegib phosphate: Smoothened (SMO) receptor antagonist oncolytic

Drugs of the Future, 2014
null Salati, M., null Stathis, A.
openaire   +1 more source

Home - About - Disclaimer - Privacy